884 related articles for article (PubMed ID: 17008110)
1. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
Molnár I; Bokk A
Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
[TBL] [Abstract][Full Text] [Related]
2. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
Molnár I
Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
[TBL] [Abstract][Full Text] [Related]
3. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
[TBL] [Abstract][Full Text] [Related]
5. Hashimoto's thyroiditis following Graves' disease.
Umar H; Muallima N; Adam JM; Sanusi H
Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
[TBL] [Abstract][Full Text] [Related]
6. Detectable serum IgE levels in Graves' ophthalmopathy.
Molnár I; Horváth S; Balázs C
Eur J Med Res; 1996 Sep; 1(11):543-6. PubMed ID: 9438158
[TBL] [Abstract][Full Text] [Related]
7. Four patients with hypothyroid Graves' disease.
Starrenburg-Razenberg AJ; Castro Cabezas M; Gan IM; Njo TL; Rietveld AP; Elte JW
Neth J Med; 2010 Apr; 68(4):178-80. PubMed ID: 20421660
[TBL] [Abstract][Full Text] [Related]
8. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
[TBL] [Abstract][Full Text] [Related]
9. Increased serum neopterin levels in patients with Graves' disease.
Wagner R; Hayatghebi S; Rosenkranz M; Reinwein D
Exp Clin Endocrinol; 1993; 101(4):249-54. PubMed ID: 8307114
[TBL] [Abstract][Full Text] [Related]
10. UCLA conference. Autoimmune thyroid diseases--Graves' and Hashimoto's.
Ann Intern Med; 1978 Mar; 88(3):379-91. PubMed ID: 204241
[TBL] [Abstract][Full Text] [Related]
11. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
[TBL] [Abstract][Full Text] [Related]
12. A differential association of interferon-gamma high-producing allele T and low-producing allele A (+874 A/T) with Hashimoto's thyroiditis and Graves' disease.
Rekha PL; Ishaq M; Valluri V
Scand J Immunol; 2006 Oct; 64(4):438-43. PubMed ID: 16970687
[TBL] [Abstract][Full Text] [Related]
13. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
Wakelkamp IM; Prummel MF; Wiersinga WM
Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406
[TBL] [Abstract][Full Text] [Related]
14. Soluble intercellular adhesion molecule-1 (sICAM-1) in Graves' disease.
Balázs C; Kiss E
Acta Microbiol Immunol Hung; 1994; 41(4):451-6. PubMed ID: 7866729
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin binding inhibiting immunoglobulins (TBII) in Graves' disease, toxic nodular goitre and autoimmune thyroiditis.
Wägar G; Mäkinen T; Lamberg BA; Gordin A; Apter L; Pekonen F
Ann Clin Res; 1982 Apr; 14(2):83-9. PubMed ID: 6184007
[TBL] [Abstract][Full Text] [Related]
16. Association of circulating antibodies against double-stranded and single-stranded DNA with thyroid autoantibodies in Graves' disease and Hashimoto's thyroiditis patients.
Pedro AB; Romaldini JH; Americo C; Takei K
Exp Clin Endocrinol Diabetes; 2006 Jan; 114(1):35-8. PubMed ID: 16450315
[TBL] [Abstract][Full Text] [Related]
17. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of serum levels of ghrelin and obestatin in children and adolescents with autoimmune thyroid diseases].
Sawicka B; Bossowski A; Urban M; Szalecki M; Wysocka J; Koput A; Zelazowska-Rutkowska B; Tobolczyk J; Skrzydło M; Rogowski F; Luba M
Pediatr Endocrinol Diabetes Metab; 2009; 15(1):20-7. PubMed ID: 19454185
[TBL] [Abstract][Full Text] [Related]
20. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]